COVID-KOSHA
Home
Help
(current)
!
Note: Language translations may be imperfect
A model anti-pandemic portal for scientists & public
Others.
Last updated: 2021 Dec 8
Total hit(s): 13
---Sort by---
Key findings ▲
Key findings ▼
Date of publishing ▲
Date of publishing ▼
Citation Count ▲
Citation Count ▼
Impact Factor ▲
Impact Factor ▼
Select item(s)
Key Findings
Comments
(You can add your comments too!)
Original Article
(hover to see details)
A lineage-specific single nucleotide polymorphism
(SNP)
-targeting allele-specific probe polymerase chain reaction (ASP-PCR) was developed. This new technique identified SARS-CoV-2
Alpha
variant with an accuracy of 99.93%.
✍
Pre-print
(
medRXiv
)
Date of Publishing
2021 Nov 02
Title
Highly-Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe Polymerase Chain Reaction
Impact factor
N/A
Date of Entry
2021 Dec 8
A lineage-specific single nucleotide polymorphism
(SNP)
-targeting allele-specific probe polymerase chain reaction (ASP-PCR) was developed. This new technique identified SARS-CoV-2
Gamma
(P1) variant with an accuracy of 99.42%.
✍
Pre-print
(
medRXiv
)
Date of Publishing
2021 Nov 02
Title
Highly-Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe Polymerase Chain Reaction
Impact factor
N/A
Date of Entry
2021 Dec 8
A lineage-specific single nucleotide polymorphism
(SNP)
-targeting allele-specific probe polymerase chain reaction (ASP-PCR) was developed. This new technique identified SARS-CoV-2 Zeta
(P2)
variant with an accuracy of 99.69%.
✍
Pre-print
(
medRXiv
)
Date of Publishing
2021 Nov 02
Title
Highly-Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe Polymerase Chain Reaction
Impact factor
N/A
Date of Entry
2021 Dec 8
The kinetics of
binding
of soluble
ACE2
to recombinant RBD was assessed by biolayer interferometry (BLI). The affinity of the
B.1.351
RBD to
ACE2
was 19-fold higher when compared to the wildtype and 2.7-fold higher when compared to the
alpha
variant.
✍
33730597
(
Cell
)
PMID
33730597
Date of Publishing
: 2021 Apr 29
Title
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
Author(s) name
Zhou D, Dejnirattisai W et al.
Journal
Cell
Impact factor
27.35
Citation count
: 406
Date of Entry
2021 Nov 2
×
NLM format
Zhou D, Dejnirattisai W, Supasa P, Liu C, Mentzer AJ, Ginn HM, Zhao Y, Duyvesteyn HME, Tuekprakhon A, Nutalai R, Wang B, Paesen GC, Lopez-Camacho C, Slon-Campos J, Hallis B, Coombes N, Bewley K, Charlton S, Walter TS, Skelly D, Lumley SF, Dold C, Levin R, Dong T, Pollard AJ, Knight JC, Crook D, Lambe T, Clutterbuck E, Bibi S, Flaxman A, Bittaye M, Belij-Rammerstorfer S, Gilbert S, James W, Carroll MW, Klenerman P, Barnes E, Dunachie SJ, Fry EE, Mongkolsapaya J, Ren J, Stuart DI, Screaton GR. Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera. Cell. 2021 Apr 29;184(9):2348-2361.e6. PMID:33730597
SARS-CoV-2
Delta
variant has a higher replication fitness compared to
Alpha
variant as studied in in-vitro respiratory SARS-CoV-2 models. The
Delta
vs
Alpha
RNA ratio increased from 1.7 on day 1 to 3.1 on day 5.
The furin cleavage site mutation P681R plays a key function in increasing the Delta variant's replication in basic human airway cultures.
✍
Pre-print
(
bioRXiv
)
Title
Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant
Impact factor
N/A
Date of Entry
2021 Sep 30
The
D614G
spike
mutation
results in increased viral transduction. However, there was no change in the
binding
profiles of soluble D614 and G614 spike to human
ACE2.
The two dissociation constants
(KD)
were: KD1 = 8.45 nM and KD2 = 127 nM for D614 variant, and KD1 = 18.0 nM and KD2 = 92.7 nM for G614 variant.
✍
32587969 (33570490)
(
bioRxiv
)
PMID
32587969 (33570490)
Date of Publishing
: 2020 Jun 15
Title
The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types
Author(s) name
Daniloski Z, Guo X, Sanjana NE.
Journal
bioRxiv
Impact factor
N/A
Citation count
: 2
Date of Entry
2021 Sep 13
×
NLM format
Daniloski Z, Guo X, Sanjana NE. The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types. bioRxiv. . PMID:32587969 (33570490)
Structure analysis of SARS-CoV-2 N439K Receptor
Binding
Domain (RBD) in complex with hACE2 at 2.8 resolution showed strong non-covalent salt bridges. These bridges enhanced the
binding
for hACE2 in the N439K variant, as similar to the SARS-CoV N439R variant. Double mutants of N439K/R and K417V mutations show that salt bridge loss at RBD position 417 is compensated by the one at position 439. This results in hACE2 affinity similar to the wild type.
Methods used for study: X-ray structure, Surface plasmon resonance (SPR)
✍
33621484
(
Cell
)
PMID
33621484
Date of Publishing
: 2021 Jan 28
Title
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
Author(s) name
Thomson EC, Rosen LE et al.
Journal
Cell
Impact factor
27.35
Citation count
: 259
Date of Entry
2021 Aug 6
×
NLM format
Thomson EC, Rosen LE, Shepherd JG, Spreafico R, da Silva Filipe A, Wojcechowskyj JA, Davis C, Piccoli L, Pascall DJ, Dillen J, Lytras S, Czudnochowski N, Shah R, Meury M, Jesudason N, De Marco A, Li K, Bassi J, O'Toole A, Pinto D, Colquhoun RM, Culap K, Jackson B, Zatta F, Rambaut A, Jaconi S, Sreenu VB, Nix J, Zhang I, Jarrett RF, Glass WG, Beltramello M, Nomikou K, Pizzuto M, Tong L, Cameroni E, Croll TI, Johnson N, Di Iulio J, Wickenhagen A, Ceschi A, Harbison AM, Mair D, Ferrari P, Smollett K, Sallusto F, Carmichael S, Garzoni C, Nichols J, Galli M, Hughes J, Riva A, Ho A, Schiuma M, Semple MG, Openshaw PJM, Fadda E, Baillie JK, Chodera JD; ISARIC4C Investigators; COVID-19 Genomics UK (COG-UK) Consortium, Rihn SJ, Lycett SJ, Virgin HW, Telenti A, Corti D, Robertson DL, Snell G. Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity. Cell. 2021 Mar 4;184(5):1171-1187.e20. PMID:33621484
The
binding
kinetics of the
spike protein
of
alpha
variant and spike of the
D614G
variant was compared by biolayer interferometry (BLI). A 2-fold decrease was observed in the dissociation constant
(Kd)
of spike in the
alpha
variant (Kd=1.3nM) compared to the
D614G
variant (Kd=3.1nM).
✍
Pre-print
(
bioRXiv
)
Title
Impacts on the structure-function relationship of SARS-CoV-2 spike by B.1.1.7 mutations
Impact factor
N/A
Date of Entry
2021 Aug 6
The Y453F and
L452R
mutations significantly increased the
binding
affinity to human
ACE2
(RBD parental
KD
= 2.05 0.26 nM; RBD Y453F
KD
= 0.51 0.06 nM; RBD
L452R
KD = 1.20 0.06 nM)
✍
Pre-print
(
bioRXiv
)
Title
An emerging SARS-CoV-2 mutant evading cellular immunity and increasing viral infectivity
Impact factor
N/A
Date of Entry
2021 Aug 6
There were no changes in the symptoms or duration of the disease in cases associated with the SARS-CoV-2
Alpha
variant.
Vaccines were likely to remain effective against the Alpha variant owing to no changes in the reinfection rates.
✍
doi
Date of Publishing
2021 Apr 12
Title
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study
Impact factor
N/A
Date of Entry
2021 Jul 2
The most common symptoms associated with the SARS-CoV-2
Alpha
variant was
Sore throat,
Myalgia, and
Fatigue.
✍
doi
Date of Publishing
2021 Jan 27
Title
Covid-19: Sore throat, fatigue, and myalgia are more common with new UK variant
Impact factor
N/A
Date of Entry
2021 Jul 2
A multiplex RT-qPCR assay was designed to identify and differentiate between the
B.1.1.7
and the
B.1.351
variants. The assay can detect the
B.1.1.7
specific D3L
mutation
and the
B.1.351
specific 242-244
deletion
mutation.
This assay can be used for the rapid and precise differentiation of the alpha and beta variants
✍
Pre-print
(
medRXiv
)
Date of Publishing
2021 May 22
Title
Rapid And high throughput RT-qPCR assay for identification and differentiation between SARS-CoV-2 variants-Alpha (B.1.1.7) and Beta (B.1.351)
Impact factor
N/A
Date of Entry
2021 Jul
Xenonucleic acids (XNA)-based multiplex qPCR testing kit was developed to detect the SARS CoV-2 variants. The kit helps in identifying the D614G
mutation
and
N501Y
mutations in SARS-CoV-2.
Owing to the stronger hybridization of XNA/DNA than DNA, XNAs are used to target specific nucleic sequences allowing for more accurate and robust results. DG614 variant (B.1.1.7) is now prevalent in the United States due to its higher transmissibility and infective rates than expected. N501Y variant belonging to the clade of the former has independently developed in the UK and has the potential to emerge as the dominant variant.
✍
Pre-print
(
medRXiv
)
Date of Publishing
2021 Apr 05
Title
A Rapid SARS-CoV-2 Variant Detection by Molecular-Clamping Based RT-qPCR
Impact factor
N/A
Date of Entry
2021 Jul